Development of Consensus Guidelines for Anticardiolipin and Lupus Anticoagulant Testing

ABSTRACT

Interlaboratory and intermethod variation in commercial and in-house tests used for the measurement of anticardiolipin antibodies (aCL) and lupus anticoagulant (LA) limit the diagnostic value of the results from these tests. This short review summarizes published and unpublished guidelines (some developed using consensus procedures) on aCL and LA testing that are aimed at decreasing assay variation.

Cardiolipin - consensus guidelines - lupus anticoagulant - recommendation - standardization

REFERENCES

• 1 Favaloro E J, Wong R CW, Silvestrini R et al.. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin and beta₂-glycoprotein I antibody testing.  Semin Thromb Hemost. 2005;  31 73-84
• 2 Harris E N, Pierangeli S S. Revisiting the anticardiolipin test and its standardization.  Lupus. 2002;  11 269-275
• 3 Favaloro E J, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing.  Am J Clin Pathol. 2002;  118 548-557
• 4 Roberts J M, Macara L M, Chalmers E A, Smith G C. Inter-assay variation in antiphospholipid antibody testing.  BJOG. 2002;  109 348-349
• 5 Tincani A, Allegri F, Sanmarco M et al.. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum.  Thromb Haemost. 2001;  86 575-583
• 6 Fontaine M, Homburger H A, Nichols W L. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies.  Thromb Haemost. 2001;  86 1123-1124
• 7 Favaloro E J, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach.  Pathology. 1999;  31 142-147
• 8 Reber G, Arvieux J, Comby E et al.. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose).  Thromb Haemost. 1995;  73 444-452
• 9 Coulam C B, McIntyre J A, Wagenknecht D, Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies.  Lancet. 1990;  335 865
• 10 Green D, Hougie C, Kazmier F J et al.. Report of the Working Party on Acquired Inhibitors of Coagulation: Studies of the “lupus” anticoagulant.  Thromb Haemost. 1983;  49 144-146
• 11 Exner T, Triplett D A, Taberner D, Machin S J. Guidelines for Testing and Revised Criteria for Lupus Anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants.  Thromb Haemost. 1991;  65 320-322
• 12 Exner T, Triplett D A, Taberner D A, Howard M A, Harris E N. Comparison of test methods for the lupus anticoagulant: International Survey on Lupus Anticoagulants-I (ISLA-1).  Thromb Haemost. 1990;  64 478-484
• 13 Brandt J T, Barna L K, Triplett D A. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH.  Thromb Haemost. 1995;  74 1597-1603
• 14 Brandt J T, Triplett D A, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.  Thromb Haemost. 1995;  74 1185-1190
• 15 Jennings I, Greaves M, Mackie I J et al.. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods.  Br J Haematol. 2002;  119 364-369
• 16 Jennings I, Kitchen S, Woods T A, Preston F E, Greaves M. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.  Thromb Haemost. 1997;  77 934-937
• 17 Roussi J, Roisin J P, Goguel A. Lupus anticoagulants: first French interlaboratory Etalonorme survey.  Am J Clin Pathol. 1996;  105 788-793
• 18 Arnout J. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants.  Thromb Haemost. 2001;  86 83-91
• 19 Lawrie A S, Mackie I J, Purdy G, Machin S J. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.  Thromb Haemost. 1999;  81 758-762
• 20 Arnout J, Meijer P, Vermylen J. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.  Thromb Haemost. 1999;  81 929-934
• 21 Wong R CW, Favaloro E J, Pollock W et al.. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays.  Pathology. 2004;  36 182-192
• 22 Wilson W A, Gharavi A E, Koike T et al.. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.  Arthritis Rheum. 1999;  42 1309-1311
• 23 Lockshin M D, Sammaritano L R, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome.  Arthritis Rheum. 2000;  43 440-443
• 24 Wilson W A. Classification criteria for antiphospholipid syndrome.  Rheum Dis Clin North Am. 2001;  27 499-505
• 25 Moons K GM, Grobbee D E. When should we remain blind and when should our eyes remain open in diagnostic studies?.  J Clin Epidemiol. 2002;  55 633-636
• 26 Swets J A. Measuring the accuracy of diagnostic systems.  Science. 1998;  240 1285-1293
• 27 Ransohoff D F, Feinstein A R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.  N Engl J Med. 1978;  299 926-930
• 28 Giles I P, Isenberg D A, Latchman D S, Rahman A. How do antiphospholipid antibodies bind beta2-glycoprotein I?.  Arthritis Rheum. 2003;  48 2111-2121
• 29 Harris E N, Gharavi A E, Patel S, Hughes G RV. Evaluation of the anticardiolipin antibody test: report of an International Workshop held April 4 1986.  Clin Exp Immunol. 1987;  68 215-222
• 30 Harris E N. The second International Anticardiolipin Standardization Workshop/the Kingston Antiphospholipid Antibody study (KAPS) group.  Am J Clin Pathol. 1990;  94 476-484
• 31 Harris E N, Pierangeli S S, Birch D. Anticardiolipin wet workshop: Vth International Symposium on antiphospholipid antibodies.  Am J Clin Pathol. 1994;  101 616-624
• 32 Pierangeli S S, Stewart M, Silva L K, Harris E N. Report of an anticardiolipin wet workshop during the VIIth International Symposium on antiphospholipid antibodies.  J Rheumatol. 1998;  25 156-162
• 33 Ichikawa K, Khamashta M A, Koike T, Matsuura E, Hughes G RV. Beta 2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome.  Arthritis Rheum. 1994;  37 1453-1461
• 34 Ichikawa K, Tsutsumi A, Atsumi T et al.. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.  Arthritis Rheum. 1999;  42 2461-2470
• 35 Greaves M, Cohen H, MacHin S J, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome.  Br J Haematol. 2000;  109 704-715
• 36 Triplett D A. Antiphospholipid antibodies.  Arch Pathol Lab Med. 2002;  126 1424-1429
• 37 Wong R CW, Gillis D, Adelstein S et al.. Consensus Guidelines on Anti-Cardiolipin Antibody Testing and Reporting.  Pathology. 2004;  36 63-68
• 38 Scientific and Standardisation Committee (SSC) of the International Society for Thrombosis and Haemostasis for Lupus Anticoagulants/Phospholipid-Dependent-Antibodies (2003 meeting minutes) .Available at www.med.unc.edu/isth/; select “SSC Official Communications,” then “All 2003 Scientific Subcommittee Reports,” then “Lupus Anticoagulant/Phospholipid-dependent Antibodies Accessed January 5, 2005
• 39 Favaloro E J, Bonar R, Sioufi J et al.. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Programs for Hematology.  Semin Thromb Hemost. 2005;  31 49-58
• 40 Favaloro E J. Learning from peer assessment: the role of the external quality assurance multilaboratory thrombophilia test process. Semin Thromb Hemost 2005 31: 85-89
• 41 Cabral A R, Cabiedes J, Alarcon-Segovia D. Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I.  J Immunol Methods. 1994;  175 107-114
• 42 Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.  Blood. 2003;  101 1827-1832
• 43 Agopian M S, Boctor F N, Peter J B. False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor.  Arthritis Rheum. 1988;  31 1212-1213